Zacks Research Issues Positive Forecast for IRWD Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings estimates for Ironwood Pharmaceuticals in a research note issued on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the biotechnology company will post earnings per share of $0.03 for the quarter, up from their […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings estimates for Ironwood Pharmaceuticals in a research note issued on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the biotechnology company will post earnings per share of $0.03 for the quarter, up from their […]
